BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31011797)

  • 1. Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension.
    Nakajima A; Shinbo K; Oota A; Kinoshita Y
    J Gastroenterol; 2019 Sep; 54(9):792-803. PubMed ID: 31011797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol 3350 plus electrolytes for pediatric chronic constipation: An open-label clinical study in Japan.
    Gondo M; Nagata S; Shinbo K; Oota A; Tomomasa T
    Pediatr Int; 2020 May; 62(5):600-608. PubMed ID: 31845426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial.
    Bekkali NLH; Hoekman DR; Liem O; Bongers MEJ; van Wijk MP; Zegers B; Pelleboer RA; Verwijs W; Koot BGP; Voropaiev M; Benninga MA
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):10-15. PubMed ID: 28906317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial.
    Nurko S; Youssef NN; Sabri M; Langseder A; McGowan J; Cleveland M; Di Lorenzo C
    J Pediatr; 2008 Aug; 153(2):254-61, 261.e1. PubMed ID: 18534221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.
    Chapman RW; Stanghellini V; Geraint M; Halphen M
    Am J Gastroenterol; 2013 Sep; 108(9):1508-15. PubMed ID: 23835436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
    Di Lorenzo C; Khlevner J; Rodriguez-Araujo G; Xie W; Huh SY; Ando M; Hyams JS; Nurko S; Benninga MA; Simon M; Hewson ME; Saps M
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):238-250. PubMed ID: 38211604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation.
    Corazziari E; Badiali D; Habib FI; Reboa G; Pitto G; Mazzacca G; Sabbatini F; Galeazzi R; Cilluffo T; Vantini I; Bardelli E; Baldi F
    Dig Dis Sci; 1996 Aug; 41(8):1636-42. PubMed ID: 8769292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study.
    Hardikar W; Cranswick N; Heine RG
    J Paediatr Child Health; 2007; 43(7-8):527-31. PubMed ID: 17635680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study.
    Thomson MA; Jenkins HR; Bisset WM; Heuschkel R; Kalra DS; Green MR; Wilson DC; Geraint M
    Arch Dis Child; 2007 Nov; 92(11):996-1000. PubMed ID: 17626140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study.
    Kasugai K; Iwai H; Kuboyama N; Yoshikawa A; Fukudo S
    J Gastroenterol; 2019 Jun; 54(6):530-540. PubMed ID: 30643982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation.
    Chaussade S; Minić M
    Aliment Pharmacol Ther; 2003 Jan; 17(1):165-72. PubMed ID: 12492746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
    Dipalma JA; Cleveland MV; McGowan J; Herrera JL
    Am J Gastroenterol; 2007 Jul; 102(7):1436-41. PubMed ID: 17403074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative.
    Savino F; Viola S; Erasmo M; Di Nardo G; Oliva S; Cucchiara S
    BMC Pediatr; 2012 Nov; 12():178. PubMed ID: 23152962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications.
    DiPalma JA; Cleveland MB; McGowan J; Herrera JL
    South Med J; 2007 Nov; 100(11):1085-90. PubMed ID: 17984738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults.
    Chen CC; Su MY; Tung SY; Chang FY; Wong JM; Geraint M
    Curr Med Res Opin; 2005 Oct; 21(10):1595-602. PubMed ID: 16238899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    Nakajima A; Seki M; Taniguchi S
    J Gastroenterol; 2018 Apr; 53(4):525-534. PubMed ID: 28840422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.